Warning Letters Up, Drug Recalls Down in FY 2023 CDER Drug Quality Report

Warning letters to FDA-registered drug manufacturing sites rose in 2023 while product recalls declined, recent trends that represent a sampling of CDER’s data-laden “2023 Report on the State of Pharmaceutical Quality” released last week.
Source: Drug Industry Daily